Basilar artery aneurysm: A new finding in classic infantile pompe disease

Muscle and Nerve

Volumn 47, Issue 4, 2013, Pages 613-615

  Patel, Trusha T ^a   Banugaria, Suhrad G ^a   Frush, Donald P ^a   Enterline, David S ^a   Tanpaiboon, Pranoot ^b   Kishnani, Priya S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE;

ALLELE; BASILAR ARTERY; BASILAR ARTERY ANEURYSM; BRAIN ARTERY ANEURYSM; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; ENZYME REPLACEMENT; EPIDURAL HEMATOMA; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; INFANT DISEASE; INFANTILE POMPE DISEASE; LETTER; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; WESTERN BLOTTING;

BASILAR ARTERY; CHILD; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; INTRACRANIAL ANEURYSM; MAGNETIC RESONANCE ANGIOGRAPHY;

EID: 84875615706     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23659     Document Type: Letter

References (7)

1. Laforet P, Petiot P, Nicolino M, Orlikowski D, Callaud C, Pelligrini N, et al. Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology 2008;70:2063-2066.
2. Prater SN, Banugaria SG, Dearmey SM, Botha EG, Stege EM, Case LE, et al. The emerging phenotype of long-term survivors with infantile Pompe disease. Genet Med 2012;14:800-810.
3. Sacconi S, Bocquet JD, Chanelet S, Tanant V, Salviati L, Desnuelle C. Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol 2010;257:1730-1733.
4. El-Gharbawy AH, Bhat G, Murillo JE, Thurberg BL, Kampmann C, Mengel KE, et al. Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered. Mol Genet Metab 2011;103:362-366.
5. Thurberg BL, Lynch Maloney C, Vaccaro C, Afonso K, Tsai AC, Bossen E, et al. Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest 2006;86:1208-1220.
6. Kobayashi H, Shimada Y, Ikegami M, Kawai T, Sakurai K, Urashima T, et al. Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab 2010;100:14-19.
7. Makos MM, McComb RD, Hart MN, Bennett DR. Alpha-glucosidase deficiency and basilar artery aneurysm: report of a sibship. Ann Neurol 1987;22:629-633.